Abstract
Viruses have many strategies for negotiating entry into cells and harnessing the cellular machinery for their propagation [1, 2]. The diversity of strategies is however bound by the central process of translating protein from RNA. The co-evolution of cellular responses to signature viral RNA intermediates and the counter measures employed by viruses, highlight the vulnerability of this aspect of viral replication and the potential of viral RNA as a drug target. In this review we will discuss novel efforts to target the RNA intermediates of the HIV life cycle.
Keywords: RNA Interference, Hairpin Ribozymes, HIV replication, Transdominant Rev Mutant Proteins, Rev Response Element (RRE)
Current Drug Targets
Title: RNA as A Target for Host Defense and Anti-HIV Drugs
Volume: 7 Issue: 12
Author(s): G. C. Fanning
Affiliation:
Keywords: RNA Interference, Hairpin Ribozymes, HIV replication, Transdominant Rev Mutant Proteins, Rev Response Element (RRE)
Abstract: Viruses have many strategies for negotiating entry into cells and harnessing the cellular machinery for their propagation [1, 2]. The diversity of strategies is however bound by the central process of translating protein from RNA. The co-evolution of cellular responses to signature viral RNA intermediates and the counter measures employed by viruses, highlight the vulnerability of this aspect of viral replication and the potential of viral RNA as a drug target. In this review we will discuss novel efforts to target the RNA intermediates of the HIV life cycle.
Export Options
About this article
Cite this article as:
Fanning C. G., RNA as A Target for Host Defense and Anti-HIV Drugs, Current Drug Targets 2006; 7 (12) . https://dx.doi.org/10.2174/138945006779025310
DOI https://dx.doi.org/10.2174/138945006779025310 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Endocannabinoids: A New Family of Lipid Mediators Involved in the Regulation of Neural Cell Development
Current Pharmaceutical Design Human Chorionic Gonadotropin: A Model Molecule For Oligopeptide-Based Drug Discovery
Endocrine, Metabolic & Immune Disorders - Drug Targets Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Regulation of Leptin Receptor Expression in Human Polarized Caco-2/15 Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Adverse Cardiovascular Effects of Antirheumatic Drugs: Implications for Clinical Practice and Research
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Cancer Drug Targets Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Can Surgery for Inflammatory Bowel Disease be Personalized?
Current Drug Targets MicroRNAs and Cancer; an Overview
Current Pharmaceutical Biotechnology Near-Infrared Quantum Dot Contrast Agents for Fluorescence Tissue Imaging: A Phantom Study
Current Nanoscience Molecular Features, Markers, Drug Targets, and Prospective Targeted Therapeutics in Cardiac Myxoma
Current Cancer Drug Targets Quantitative Structure Activity Relationship (QSAR) Analysis of Substituted 4-Oxothiazolidines and 5-Arylidines as Lipoxygenase Inhibitors
Mini-Reviews in Medicinal Chemistry The C-Terminal Half of Heat Shock Protein 90 Represents a Second Site for Pharmacologic Intervention in Chaperone Function
Current Cancer Drug Targets Total Lipids and Fatty Acid Methyl Esters of Germinated Seeds of Mangrove Wild Legume
Current Nutrition & Food Science The Promise of Antimicrobial Peptides for Treatment of Human Schistosomiasis
Current Drug Targets Editorial (Thematic Issue: Targeting Cell Death and Proliferation Receptors in Cancer)
Current Pharmaceutical Design ICG-001, A Novel Small Molecule Regulator of TCF/β-Catenin Masakatsu Transcription
Medicinal Chemistry Editorial [Hot Topic Biomarkers, Molecular Imaging, and Novel Therapies of Cancer]
Current Molecular Medicine Recent Advances in Oncogenic Roles of the TRPM7 Chanzyme
Current Medicinal Chemistry Integrating Virtual Screening and Combinatorial Chemistry for Accelerated Drug Discovery
Combinatorial Chemistry & High Throughput Screening